CA-NETAPP
5.3.2024 14:01:30 CET | Business Wire | Press release
NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced cyber-resiliency capabilities that will equip customers to better protect and recover their data in the face of ransomware threats. NetApp is one of the first to integrate artificial intelligence (AI) and machine learning (ML) directly into enterprise primary storage to fight ransomware in real-time. The NetApp cyber-resiliency capabilities protect both primary and secondary data for organizations whether it is stored on-premises or in the cloud.
Cybercriminals are increasingly aiming ransomware attacks at critical infrastructure and supply chains where operational disruptions can cost millions of dollars, according to Forrester. As a result, 87 percent of C-suite and board-level executives ranked ransomware as a high, or the top, priority for their organization, according to the NetApp 2023 Data Complexity report. When cybercriminals breach perimeters, networks, and identities storage becomes the last line of defense for organizations’ most critical data. With the threat of ransomware looming, organizations need solutions that not only protect their data but also quickly recover lost data and return to normal operations. NetApp is updating its cyber-resiliency solutions and leveraging the power of AI to give customers confidence that their data will be safe and accessible when they need it.
“NetApp is taking an aggressive and proactive approach to protecting our customers’ data against cyber threats using artificial intelligence. We are the first storage vendor to explicitly and financially guarantee our data storage offerings against ransomware,” said Mignona Cote, CSO at NetApp. “Today, we are furthering that leadership with updates that make defending data comprehensive, continuous, and simple for our customers.”
NetApp is focused on designing data storage and management systems that maximize data protection and security while meeting data governance and compliance standards, with new updates that include:
- ONTAP Autonomous Ransomware Protection with Artificial Intelligence (ARP/AI) will spearhead the next generation of real-time enterprise storage ransomware protection, giving increased accuracy and performance required to detect and mitigate new, more sophisticated cyber threats. NetApp pioneered autonomous real-time detection of ransomware directly in primary enterprise storage three years ago. Now, NetApp will be leading the charge to use adaptive AI/ML models built directly into enterprise primary storage to look at file-level signals in real-time to detect even the newest ransomware attacks with planned 99%+ precision and recall. NetApp will be offering the first technology preview of ARP/AI within the next quarter.
- NetApp BlueXP Ransomware Protection, now in public preview, provides a single control plane to intelligently coordinate and execute an end-to-end, workload-centric ransomware defense. Customers can now identify and protect critical workload data with a single click, accurately and automatically detect and respond to a potential attack, and recover workloads within minutes, safeguarding their valuable data and minimizing costly disruption.
- Application-Aware Ransomware Protection via NetApp SnapCenter 5.0 offers immutable ransomware protection for applications. SnapCenter will now apply NetApp's leading ransomware protection technologies, previously used with unstructured data, to application-consistent backup. SnapCenter 5.0 includes support for key ONTAP features like tamperproof Snapshot copy locking, SnapLock protected volumes, and SnapMirror Business Continuity to enable more robust data protection for applications and virtual machines. SnapCenter 5.0 supports protection of applications on-premises with NetApp AFF, ASA, and FAS, as well as in the cloud.
- NetApp BlueXP Disaster Recovery, now generally available, offers seamless integration with VMware infrastructure and provides storage options for both on-premises and major public cloud environments. This comprehensive solution eliminates the need for separate standby disaster recovery (DR) infrastructure, reducing costs. With NetApp BlueXP disaster recovery, failover and failback processes are simplified, allowing smooth transitions from on-premises VMware infrastructure to the public cloud or to an on-premises data center.
- NetApp Keystone Ransomware Recovery Guarantee extends NetApp’s current Ransomware Recovery Guarantee to our leading storage-as-a-service offering, NetApp Keystone. With this guarantee, NetApp will warrant snapshot data recovery in the event of a ransomware attack. If snapshot data copies can’t be recovered through NetApp, we will offer compensation*.
“Today’s cybersecurity teams face the monumental task of protecting their companies’ data from ever-evolving threats, especially ransomware,” said Archana Venkatraman, Research Director, Cloud Data Management, IDC. “NetApp’s approach of delivering a secure, unified storage infrastructure makes storage foundational for ransomware protection and reduces the burden on cybersecurity teams. Companies looking to fortify their cyber resiliency and shifting protection left will increasingly look to vendors that take a secure-by-design approach and develop unified storage and data services.”
“Using NetApp in our Advanced Technology Center, we significantly simplified our replication process for VMware virtual machines and their underlying datastores to meet or exceed recovery benchmarks,” said Derek Elbert, Solutions Architect at WWT. “With NetApp’s solutions, we successfully established the recovery policies for cloud volumes workloads or virtual machines with no existing DR strategy, managing everything through NetApp BlueXP. This transforms how we operate disaster recovery for VMware.”
“To store sensitive genomics and health data, we have to use the right technology with layers of security built in,” said Mark Cowley, Deputy Director at Children’s Cancer Institute. “With NetApp, we can be very confident that we are sharing the right data only to authorized researchers. The last line of defense is your weakest web-based system, so we’ve implemented role-based access and added resilience to all of our tools.”
The latest cyber resiliency updates from NetApp empower organizations to proactively address cybersecurity threats in complex hybrid and multicloud environments, leveraging AI to identify threats and prevent disruptions to their operations.
To learn more about the NetApp cyber-resiliency offerings visit: https://www.netapp.com/cyber-resilience/
*Specific terms and conditions will apply. Customers must apply for coverage by the guarantee.
Additional Resources
About NetApp
NetApp is the intelligent data infrastructure company, combining unified data storage, integrated data services, and CloudOps solutions to turn a world of disruption into opportunity for every customer. NetApp creates silo-free infrastructure, harnessing observability and AI to enable the industry’s best data management. As the only enterprise-grade storage service natively embedded in the world’s biggest clouds, our data storage delivers seamless flexibility. In addition, our data services create a data advantage through superior cyber resilience, governance, and application agility. Our CloudOps solutions provide continuous optimization of performance and efficiency through observability and AI. No matter the data type, workload, or environment, with NetApp you can transform your data infrastructure to realize your business possibilities. Learn more at www.netapp.com or follow us on X, LinkedIn, Facebook, and Instagram.
NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc. Other company and product names may be trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240305981204/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
